Elicio Therapeutics, Inc.ELTXNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank44
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-36.59M
↓ 15% vs avg
Percentile
P44
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-31.84M
Historical baseline
PeriodValueYoY Change
TTM$-36.59M+27.2%
2024$-50.27M-52.5%
2023$-32.97M-40.0%
2022$-23.55M+54.6%
2021$-51.92M+26.5%
2020$-70.63M-75.9%
2019$-40.16M-180.1%
2018$-14.34M-23029.3%
2013$62540.00-96.8%
2012$1.96M-